blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3620452

EP3620452 - PROCESS FOR THE PREPARATION OF LENVATINIB [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  25.03.2022
Database last updated on 03.09.2024
FormerThe patent has been granted
Status updated on  16.04.2021
FormerGrant of patent is intended
Status updated on  02.12.2020
FormerRequest for examination was made
Status updated on  11.09.2020
FormerThe application has been published
Status updated on  07.02.2020
Most recent event   Tooltip03.05.2024Lapse of the patent in a contracting state
New state(s): MK
published on 05.06.2024  [2024/23]
Applicant(s)For all designated states
Indena S.p.A.
Viale Ortles, 12
20139 Milano / IT
[2020/17]
Former [2020/11]For all designated states
Indena S.p.A.
Viale Ortles, 12
20139 Milano / IT
For all designated states
UNIVERSITA' DEGLI STUDI DI MILANO
Via Festa del Perdono, 7
20122 Milano / IT
Inventor(s)01 / SENALDI, Luca
c/o INDENA S.p.A.
Viale Ortles, 12
20139 Milano / IT
02 / ALLEGRINI, Pietro
c/o INDENA S.p.A.
Viale Ortles, 12
20139 Milano / IT
03 / CICERI, Daniele
c/o INDENA S.p.A.
Viale Ortles, 12
20139 Milano / IT
04 / BERNARDI, Anna
c/o UNIVERSITA' DEGLI STUDI DI MILANO
Dipartimento di Chimica
Via Golgi, 19
20139 Milano / IT
 [2020/11]
Representative(s)Bianchetti & Minoja with Trevisan & Cuonzo IPS SRL
Via Plinio, 63
20129 Milano / IT
[N/P]
Former [2020/11]Bianchetti Bracco Minoja S.r.l.
Via Plinio, 63
20129 Milano / IT
Application number, filing date18193196.507.09.2018
[2020/11]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3620452
Date:11.03.2020
Language:EN
[2020/11]
Type: B1 Patent specification 
No.:EP3620452
Date:19.05.2021
Language:EN
[2021/20]
Search report(s)(Supplementary) European search report - dispatched on:EP11.12.2018
ClassificationIPC:C07D215/233
[2020/11]
CPC:
C07D215/233 (EP,IL,KR,US); A61K31/47 (IL,KR); C07B2200/13 (IL,US)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/42]
Former [2020/11]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  RS,  SE,  SI,  SK,  SM,  TR 
TitleGerman:VERFAHREN ZUR HERSTELLUNG VON LENVATINIB[2020/11]
English:PROCESS FOR THE PREPARATION OF LENVATINIB[2020/11]
French:PROCÉDÉ DE PRÉPARATION DE LENVATINIB[2020/11]
Examination procedure08.09.2020Amendment by applicant (claims and/or description)
08.09.2020Examination requested  [2020/42]
08.09.2020Date on which the examining division has become responsible
03.12.2020Communication of intention to grant the patent
07.04.2021Fee for grant paid
07.04.2021Fee for publishing/printing paid
07.04.2021Receipt of the translation of the claim(s)
Opposition(s)22.02.2022No opposition filed within time limit [2022/17]
Fees paidRenewal fee
23.09.2020Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAL19.05.2021
CY19.05.2021
EE19.05.2021
HR19.05.2021
LT19.05.2021
LV19.05.2021
MC19.05.2021
MK19.05.2021
RS19.05.2021
SK19.05.2021
SM19.05.2021
BG19.08.2021
LU07.09.2021
IS19.09.2021
[2024/23]
Former [2023/30]AL19.05.2021
CY19.05.2021
EE19.05.2021
HR19.05.2021
LT19.05.2021
LV19.05.2021
MC19.05.2021
RS19.05.2021
SK19.05.2021
SM19.05.2021
BG19.08.2021
LU07.09.2021
IS19.09.2021
Former [2022/34]AL19.05.2021
EE19.05.2021
HR19.05.2021
LT19.05.2021
LV19.05.2021
MC19.05.2021
RS19.05.2021
SK19.05.2021
SM19.05.2021
BG19.08.2021
LU07.09.2021
IS19.09.2021
Former [2022/25]AL19.05.2021
EE19.05.2021
HR19.05.2021
LT19.05.2021
LV19.05.2021
MC19.05.2021
RS19.05.2021
SK19.05.2021
SM19.05.2021
BG19.08.2021
IS19.09.2021
Former [2022/23]EE19.05.2021
HR19.05.2021
LT19.05.2021
LV19.05.2021
RS19.05.2021
SK19.05.2021
SM19.05.2021
BG19.08.2021
IS19.09.2021
Former [2022/10]EE19.05.2021
HR19.05.2021
LT19.05.2021
LV19.05.2021
RS19.05.2021
SK19.05.2021
SM19.05.2021
BG19.08.2021
IS22.12.2021
Former [2022/07]HR19.05.2021
LT19.05.2021
LV19.05.2021
RS19.05.2021
SM19.05.2021
BG19.08.2021
IS19.09.2021
Former [2021/51]HR19.05.2021
LT19.05.2021
LV19.05.2021
RS19.05.2021
BG19.08.2021
IS19.09.2021
Former [2021/49]HR19.05.2021
LT19.05.2021
LV19.05.2021
BG19.08.2021
Former [2021/47]LT19.05.2021
BG19.08.2021
Former [2021/46]LT19.05.2021
Documents cited:Search[AD]EP1683785  (EISAI CO LTD [JP]) [AD] 1-4 * example - *;
 [A]CN104876864B  (BEIJING KANG LISHENG PHARMACEUTICAL TECHNOLOGY DEV CO LTD) [A] 1-4* example -; claim - *;
 [A]CN106632033  (BEIJING VENTUREPHARM BIOTECH CORP) [A] 1-4 * example -; claim - *
by applicantWO0232872
 US7683172
 CN107266363
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.